Shane A. Gangatharan

St Andrews Place
East Melbourne, VIC 3002, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Journal: Lancet (London, England)

Published: October 24, 2025

Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study.

Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study.

Journal: HemaSphere

Published: July 23, 2025

Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian context.

Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian context.

Journal: Internal medicine journal

Published: July 07, 2024

Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.

Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.

Journal: British journal of haematology

Published: December 20, 2023

Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study.

Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study.

Journal: Leukemia & lymphoma

Published: November 24, 2022

COVID-19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy.

COVID-19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy.

Journal: Internal medicine journal

Published: November 07, 2022

Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.

Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.

Journal: Internal medicine journal

Published: May 24, 2022

Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Journal: Internal medicine journal

Published: May 07, 2021

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.

Journal: Internal medicine journal

Published: February 01, 2021

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.

Journal: Internal medicine journal

Published: April 08, 2020

Linezolid-resistant ST872 Enteroccocus faecium harbouring optrA and cfr (D) oxazolidinone resistance genes.

Linezolid-resistant ST872 Enteroccocus faecium harbouring optrA and cfr (D) oxazolidinone resistance genes.

Journal: International journal of antimicrobial agents

Published: May 24, 2019

Unusual case of unilateral conductive hearing loss: chronic lymphocytic leukaemia.

Unusual case of unilateral conductive hearing loss: chronic lymphocytic leukaemia.

Journal: BMJ case reports

Published: October 15, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026